{"id":15030,"date":"2025-09-18T05:40:14","date_gmt":"2025-09-17T17:40:14","guid":{"rendered":"https:\/\/thebuzz.apnanetwork.co.nz\/?p=15030"},"modified":"2025-09-18T05:40:38","modified_gmt":"2025-09-17T17:40:38","slug":"nzs-slow-uptake-of-cancer-treatments-driving-doctors-offshore","status":"publish","type":"post","link":"https:\/\/thebuzz.apnanetwork.co.nz\/?p=15030","title":{"rendered":"NZ&#8217;s slow uptake of cancer treatments driving doctors offshore"},"content":{"rendered":"<p>A New Zealand haematologist working in Australia has warned highly trained doctors are being driven offshore, along with patients, because Aotearoa is at least a decade behind in blood cancer treatments.<\/p>\n<p>Professor Judith Trotman, chair of the Australasian Leukaemia and Lymphoma Group, has treated New Zealand patients who purposefully moved across the Tasman to gain access to funded treatment like the antibody medication daratumumab.<\/p>\n<p>One of her patients, Jo Neep, told\u00a0<i>Checkpoint<\/i>\u00a0that she felt no choice but to\u00a0<a href=\"https:\/\/www.rnz.co.nz\/news\/national\/573236\/medical-migrant-seeks-life-in-australia\">move to Australia to access the life prolonging drug<\/a>, which is not funded in New Zealand.<\/p>\n<div class=\"photo-captioned photo-captioned-full photo-cntr eight_col \">\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/media.rnztools.nz\/rnz\/image\/upload\/s--aCYukAri--\/c_crop,h_4000,w_6400,x_0,y_252\/c_scale,h_4000,w_6400\/c_scale,f_auto,q_auto,w_1050\/v1758098313\/4L196V0_Judith_Trotman_jpg?_a=BACCd2AD\" alt=\"Professor Judith Trotman, chair of the Australasian Leukaemia and Lymphoma Group.\" width=\"1050\" height=\"700\" \/><\/p>\n<p class=\"photo-captioned__information\"><span class=\"caption\">Professor Judith Trotman, chair of the Australasian Leukaemia and Lymphoma Group.\u00a0<\/span><span class=\"credit\">Photo:\u00a0Sam Hubel<\/span><\/p>\n<\/div>\n<p>Daratumumab, which is funded in more than 45 other countries, has been on Pharmac&#8217;s &#8220;options for investment&#8221; list for years and is considered a high priority drug &#8211; meaning it would fund it if it had the money.<\/p>\n<p>Dr Trotman told\u00a0<i>Checkpoint<\/i>\u00a0Australia started funding daratumumab over four years ago.<\/p>\n<p>&#8220;I know this because I&#8217;ve had so many patients now up to their 50th monthly dose,&#8221; she said.<\/p>\n<p>&#8220;And yet New Zealanders are are still desperately trying on behalf of New Zealand myeloma patients to get access for it.<\/p>\n<p>&#8220;It distresses me greatly that despite the unparalleled media and community focus on the need for modern blood cancer care in Aotearoa, there&#8217;s still no funding for daratumumab.&#8221;<\/p>\n<p>rnz<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A New Zealand haematologist working in Australia has warned highly trained doctors are being driven offshore, along with patients, because Aotearoa is at least a decade behind in blood cancer treatments. Professor Judith Trotman, chair of the Australasian Leukaemia and Lymphoma Group, has treated New Zealand patients who purposefully moved across the Tasman to gain [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":15032,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[222,174],"tags":[],"class_list":["post-15030","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news","category-nz-news"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/thebuzz.apnanetwork.co.nz\/index.php?rest_route=\/wp\/v2\/posts\/15030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thebuzz.apnanetwork.co.nz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thebuzz.apnanetwork.co.nz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thebuzz.apnanetwork.co.nz\/index.php?rest_route=\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/thebuzz.apnanetwork.co.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15030"}],"version-history":[{"count":2,"href":"https:\/\/thebuzz.apnanetwork.co.nz\/index.php?rest_route=\/wp\/v2\/posts\/15030\/revisions"}],"predecessor-version":[{"id":15033,"href":"https:\/\/thebuzz.apnanetwork.co.nz\/index.php?rest_route=\/wp\/v2\/posts\/15030\/revisions\/15033"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thebuzz.apnanetwork.co.nz\/index.php?rest_route=\/wp\/v2\/media\/15032"}],"wp:attachment":[{"href":"https:\/\/thebuzz.apnanetwork.co.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15030"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thebuzz.apnanetwork.co.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15030"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thebuzz.apnanetwork.co.nz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}